Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2013 / Cilt: 22 - Sayı: 1

Requirement of emergency hemodialysis in a peritoneal dialysis patient; laxative ınduced hypermagnesemia: a case report

Periton diyalizi hastasında acil hemodiyaliz gereksinimi; laksatif kullanımına bağlı hipermagnezemi: olgu sunumu

Pages
111–113
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

HD is a dialysis modality that should be preferred in the treatment of symptomatic patients with hypermagnesemia, because of providing more rapid clearance of Mg.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypermagnesemia is rarely seen in peritoneal dialysis (PD) patients because PD can lower the plasma magnesium (Mg) concentration effectively.
📊
Key Findings & Data:A 52-year-old male patient on PD treatment was admitted to our clinic with complaints of fatigue and muscle weakness.
💡
Conclusion & Impact:HD is a dialysis modality that should be preferred in the treatment of symptomatic patients with hypermagnesemia, because of providing more rapid clearance of Mg.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hypermagnesemia is rarely seen in peritoneal dialysis (PD) patients because PD can lower the plasma magnesium (Mg) concentration effectively. In this report, a continuous ambulatory peritoneal dialysis (CAPD) patient with life-threatening hypermagnesemia treated by hemodialysis (HD) is presented. A 52-year-old male patient on PD treatment was admitted to our clinic with complaints of fatigue and muscle weakness. Decrease in deep tendon reflexes (DTR), decrease in muscle strength at bilateral upper and lower extremities, and increased level of magnesium (7.7 mg/dl) were detected. Bradycardia, prolongation of the P-R interval, and an increase in Q-T interval were found on the electrocardiography. HD was performed two times. After HD, all the signs and symptoms of the patient improved. HD is a dialysis modality that should be preferred in the treatment of symptomatic patients with hypermagnesemia, because of providing more rapid clearance of Mg.

Özet

Periton diyalizi (PD) tedavisi plazma magnezyum (Mg) konsantrasyonunu etkin olarak düşürdüğünden PD hastalarında hipermagnezemi oldukça nadir görülmektedir. Burada, sürekli ayaktan periton diyalizi (SAPD) tedavisi alan bir hastada Mg hidroksit kullanımına bağlı ortaya çıkan, hayatı tehdit eden hipermagnezemi tablosunun acil hemodiyalizle (HD) düzeltildiği bir olgu sunulmuştur. Elli iki yaşında erkek hasta son dönem böbrek yetmezliği (SDBY) nedeniyle SAPD tedavisi uygulamaktayken, halsizlik ve kas güçsüzlüğü yakınmalarıyla polikliniğimize başvurdu. Hastanın yapılan nörolojik muayenesinde; derin tendon reflekslerinde (DTR) ve bilateral alt ve üst ekstremitelerdeki kas gücünde azalma ile birlikte magnezyum düzeyinde artış (7,7 mg/dl) saptandı. Hastanın çekilen elektrokardiyografisinde (EKG) bradikardi, P-R mesafesinde ve Q-T intervalinde uzama mevcuttu. Hasta 2 kez HDe alındı. Sonrasında hastanın belirti ve bulguları düzeldi. Semptomlu hipermagnezemik hastalarda HD tedavisi daha hızlı Mg klirensi sağlayacağından tercih edilmesi gereken diyaliz modalitesidir.

🔖

Cite This Article

SEZİŞ, M. D., ÖZKAHYA, M., TAMER, A. F., BAŞÇI, A., YAPRAK, M., TURAN, M. N., BULUT, G., TATAR, E. (2022). Requirement of emergency hemodialysis in a peritoneal dialysis patient; laxative ınduced hypermagnesemia: a case report. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 22 - Sayı: 1, 111–113. https://ajindex.com/articles/636331

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Suki WN, Lederer E, Rouse D: Renal transport of calcium, magnesium and phosphate. In: Brenner BM, Rector FC (eds,). The Kidney (6th ed). Philadelphia: Saunders, 2000; 538–543 Schelling JR: Fatal hypermagnesemia. Clin Nephrol 2000; 53: 61-65
  2. Randall RE Jr, Cohen MD, Spray CC Jr, Rossmeisl EC: Hypermagnesemia in renal failure etiology and toxic manifestations. Ann Intern Med 1964; 61: 73-88 Agus ZS. Causes and treatment of hypermagnesemia. In: Uptodate. Goldfarb S (ed). UpToDate, Waltham, MA, 2011
  3. Agus ZS, Morad M: Modulation of cardiac ion channels by magnesium. Annu Rev Physiol 1991; 53: 299-307 Moss AJ: Long QT Syndrome. JAMA 2003; 289: 2041-2044
  4. Li H, Fuentes-Garcia J, Towbin JA: Current concepts in long QT syndrome. Pediatr Cardiol 2000; 21: 542-550
  5. El-Sherif N, Turitto G: Torsade de pointes. Curr Opin Cardiol 2003; 18:6-13
  6. Passman R, Kadish A: Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 2001; 85: 321-341
  7. Dai LJ, Quamme GA: Intracellular Mg2+ and magnesium depletion in isolated renal thick ascending limb cells. J Clin Invest 1991; 88 (4): 1255-1264 Quamme GA: Control of magnesium transport in the thick ascending limb. Am J Physiol 1989; 256 (2 Pt 2): 197-210
  8. Mordes JP, Wacker WE: Excess magnesium. Pharmacol Rev 1977; 29: 273-300
  9. Jung GJ, Gil HW, Yang JO, Lee EY, Hong SY: Severe hypermagnesemia causing quadriparesis in a CAPD patient. Perit Dial Int 2008; 28 (2): 206